Activation of NLRP3 inflammasome in peripheral blood mononuclear cells of PD patients results in increased plasma levels of α-syn and IL-1β, both of which aggravate the severity of dyskinesia in PD patients. The gene discussed is IL1B; the disease is Parkinson disease.